Discovery of potent PROTAC degraders of KRASG12C based on a reversible non-covalent KRAS binder

被引:1
|
作者
Zhang, Z. [1 ]
Zhai, W. [1 ]
Chen, H. [1 ]
Wang, L. [1 ]
Liu, D. [1 ]
机构
[1] Huadong Med, Global Drug Dev Ctr, Hangzhou, Peoples R China
关键词
D O I
10.1016/j.annonc.2022.01.037
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
28P
引用
收藏
页码:S14 / S14
页数:1
相关论文
共 47 条
  • [21] Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C
    Kettle, Jason G.
    Bagal, Sharan K.
    Bickerton, Sue
    Bodnarchuk, Michael S.
    Breed, Jason
    Carbajo, Rodrigo J.
    Cassar, Doyle J.
    Chakraborty, Atanu
    Cosulich, Sabina
    Cumming, Iain
    Davies, Michael
    Eatherton, Andrew
    Evans, Laura
    Feron, Lyman
    Fillery, Shaun
    Gleave, Emma S.
    Goldberg, Frederick W.
    Harlfinger, Stephanie
    Hanson, Lyndsey
    Howard, Martin
    Howells, Rachel
    Jackson, Anne
    Kemmitt, Paul
    Kingston, Jennifer K.
    Lamont, Scott
    Lewis, Hilary J.
    Li, Songlei
    Liu, Libin
    Ogg, Derek
    Phillips, Christopher
    Polanski, Radek
    Robb, Graeme
    Robinson, David
    Ross, Sarah
    Smith, James M.
    Tonge, Michael
    Whiteley, Rebecca
    Yang, Junsheng
    Zhang, Longfei
    Zhao, Xiliang
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (09) : 4468 - 4483
  • [22] KRAS inhibitor-resistance in MET-amplified KRASG12C non-small cell lung cancer
    Suzuki, Shinichiro
    Yonesaka, Kimio
    CANCER SCIENCE, 2022, 113 : 1260 - 1260
  • [23] Accelerating the Validation of Endogenous On-Target Engagement and In Cellulo Kinetic Assessment for Covalent Inhibitors of KRASG12C in Early Drug Discovery
    Kantae, Vasudev
    Polanski, Radoslaw
    Lewis, Hilary J.
    Haider, Afreen
    Barratt, Derek
    Srinivasan, Bharath
    ACS CHEMICAL BIOLOGY, 2022, 17 (08) : 2366 - 2376
  • [24] Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activity (vol 117, 105447, 2021)
    Li, Ling
    Wu, Yinrong
    Yang, Zichao
    Xu, Chenglong
    Zhao, Huiting
    Liu, Jin
    Chen, Jingxuan
    Chen, Jianjun
    BIOORGANIC CHEMISTRY, 2024, 150
  • [25] JDQ443, a Structurally Novel, Pyrazole-Based, Covalent Inhibitor of KRASG12C for the Treatment of Solid Tumors
    Lorthiois, Edwige
    Gerspacher, Marc
    Beyer, Kim S.
    Vaupel, Andrea
    Leblanc, Catherine
    Stringer, Rowan
    Weiss, Andreas
    Wilcken, Rainer
    Guthy, Daniel A.
    Lingel, Andreas
    Bomio-Confaglia, Claudio
    Machauer, Rainer
    Rigollier, Pascal
    Ottl, Johannes
    Arz, Dorothee
    Bernet, Pascal
    Desjonqueres, Gaelle
    Dussauge, Solene
    Kazic-Legueux, Malika
    Lozac'h, Marie-Anne
    Mura, Christophe
    Sorge, Mickael
    Todorov, Milen
    Warin, Nicolas
    Zink, Florence
    Voshol, Hans
    Zecri, Frederic J.
    Sedrani, Richard C.
    Ostermann, Nils
    Brachmann, Saskia M.
    Cotesta, Simona
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (24) : 16173 - 16203
  • [26] Discovery and characterization of a KRASG12C/D/V degrader with potent anti-tumor activity in KRASmut-driven preclinical models
    Li, Zhengqing
    Xu, Renqi
    Yang, Xiaofeng
    Zou, Zhengyao
    Kong, Xiaoqiang
    Chen, Haibo
    Sun, Yongqing
    Zhao, Ying
    Guo, Jing
    Yang, Cheng
    Han, Han
    Liu, Xiaoyun
    Lan, Hong
    Ding, Lieming
    Zhou, Quan
    Wu, Hao
    Wang, Jiabing
    CANCER RESEARCH, 2024, 84 (06)
  • [27] Revealing the mechanism of action of a fi rst-in-class covalent inhibitor of KRASG12C (ON) and other functional properties of oncogenic KRAS by 31 P NMR
    Sharma, Alok K.
    Pei, Jun
    Yang, Yue
    Dyba, Marcin
    Smith, Brian
    Rabara, Dana
    Larsen, Erik K.
    Lightstone, Felice C.
    Esposito, Dominic
    Stephen, Andrew G.
    Wang, Bin
    Beltran, Pedro J.
    Wallace, Eli
    Nissley, Dwight V.
    McCormick, Frank
    Maciag, Anna E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (02)
  • [28] Discovery of HYP2A,a 2nd-generation KRASG12C inhibitor exhibits potent in vivo efficacy in drug resistant tumor models
    Chen, Shoujun
    Qiang, Xiaoming
    Wang, Haibo
    Xiong, Yong
    Liu, Ke
    Liao, Dengming
    Zhong, Nan
    Liu, Mingdeng
    Mu, Xuemei
    Huang, Rudan
    Li, Min
    Gui, Dengwei
    Huang, Meilin
    Chen, Yuting
    Pan, Yuanfu
    Yao, Wengang
    Song, Yingte
    Wang, Zhongbo
    Wang, Wenbin
    Liu, Jun
    Yu, Xingchi
    Liang, Zhen
    Yuan, Yike
    Ding, Zhao
    CANCER RESEARCH, 2023, 83 (07)
  • [29] Discovery of BBO-8520, a First-In-Class Direct and Covalent Dual Inhibitor of GTP-Bound (ON) and GDP-Bound (OFF) KRASG12C
    Maciag, Anna E.
    Stice, James P.
    Wang, Bin
    Sharma, Alok K.
    Chan, Albert H.
    Lin, Ken
    Singh, Devansh
    Dyba, Marcin
    Yang, Yue
    Setoodeh, Saman
    Smith, Brian P.
    Ju, Jin Hyun
    Jeknic, Stevan
    Rabara, Dana
    Zhang, Zuhui
    Larsen, Erik K.
    Esposito, Dominic
    Denson, John-Paul
    Ranieri, Michela
    Meynardie, Mary
    Mehdizadeh, Sadaf
    Alexander, Patrick A.
    Abreu Blanco, Maria
    Turner, David M.
    Xu, Rui
    Lightstone, Felice C.
    Wong, Kwok-Kin
    Stephen, Andrew G.
    Wang, Keshi
    Simanshu, Dhirendra K.
    Sinkevicius, Kerstin W.
    Nissley, Dwight V.
    Wallace, Eli
    Mccormick, Frank
    Beltran, Pedro J.
    CANCER DISCOVERY, 2025, 15 (03) : 578 - 594
  • [30] Discovery and characterization of ABSK071, a novel and potent small-molecule covalent inhibitor for KRAS-G12C
    Guo, F.
    Zhao, Y.
    Yu, H.
    Xu, Y.
    Chen, Z.
    Yang, S.
    EUROPEAN JOURNAL OF CANCER, 2022, 174 : S22 - S23